These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21484384)

  • 1. Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.
    Sgouros G; Hobbs RF; Atkins FB; Van Nostrand D; Ladenson PW; Wahl RL
    Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S41-7. PubMed ID: 21484384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
    Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
    J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET.
    Hobbs RF; Jentzen W; Bockisch A; Sgouros G
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):79-91. PubMed ID: 23474639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.
    Lubberink M; van Schie A; de Jong HW; van Dongen GA; Teule GJ
    J Nucl Med; 2006 Aug; 47(8):1375-81. PubMed ID: 16883019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
    Jentzen W; Freudenberg L; Eising EG; Sonnenschein W; Knust J; Bockisch A
    J Nucl Med; 2008 Jun; 49(6):1017-23. PubMed ID: 18483099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison.
    Hobbs RF; Wahl RL; Lodge MA; Javadi MS; Cho SY; Chien DT; Ewertz ME; Esaias CE; Ladenson PW; Sgouros G
    J Nucl Med; 2009 Nov; 50(11):1844-7. PubMed ID: 19837771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.
    Kolbert KS; Pentlow KS; Pearson JR; Sheikh A; Finn RD; Humm JL; Larson SM
    J Nucl Med; 2007 Jan; 48(1):143-9. PubMed ID: 17204711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
    Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
    Wierts R; Brans B; Havekes B; Kemerink GJ; Halders SG; Schaper NN; Backes WH; Mottaghy FM; Jentzen W
    J Nucl Med; 2016 Jul; 57(7):1027-32. PubMed ID: 26917706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer.
    Adam DP; Grudzinski JJ; Marsh IR; Hill PM; Cho SY; Bradshaw TJ; Longcor J; Burr A; Bruce JY; Harari PM; Bednarz BP
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1275-1284. PubMed ID: 38367914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.
    Salvatori M; Luster M
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of (124)I-PET in diagnosis and treatment of thyroid carcinoma.
    Lubberink M; Abdul Fatah S; Brans B; Hoekstra OS; Teule GJ
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):30-6. PubMed ID: 17657202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.
    Jentzen W; Weise R; Kupferschläger J; Freudenberg L; Brandau W; Bares R; Burchert W; Bockisch A
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):611-23. PubMed ID: 17929014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
    Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancer.
    Freudenberg LS; Jentzen W; Marlowe RJ; Koska WW; Luster M; Bockisch A
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):690-3. PubMed ID: 18058605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in
    Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D
    J Nucl Med; 2017 Jul; 58(7):1146-1154. PubMed ID: 28104741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer.
    Weber M; Binse I; Nagarajah J; Bockisch A; Herrmann K; Jentzen W
    Q J Nucl Med Mol Imaging; 2019 Sep; 63(3):235-252. PubMed ID: 31298014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.
    Jentzen W; Balschuweit D; Schmitz J; Freudenberg L; Eising E; Hilbel T; Bockisch A; Stahl A
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2298-306. PubMed ID: 20625723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.